𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women

✍ Scribed by J. A. Kanis; F. Borgstrom; O. Johnell; B. Jonsson

Publisher
Springer-Verlag
Year
2004
Tongue
English
Weight
235 KB
Volume
15
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Seven Years of Treatment with Risedronat
Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis
✍ D. D. MellstrΓΆm; O. H. SΓΆrensen; S. Goemaere; C. Roux; T. D. Johnson; A. A. Chin πŸ“‚ Article πŸ“… 2004 πŸ› Springer 🌐 English βš– 186 KB

The effects of 7 years of risedronate treatment were evaluated in a second 2-year extension of a 3-year vertebral fracture study in women with osteoporosis. For the first 5 years of the study, women received risedronate 5 mg/day or placebo according to the original randomization, with maintenance of